SEOUL, South Korea, Jan. 11, 2024 /PRNewswire/ -- AIRS Medical, a leading AI-powered healthcare solution provider, is thrilled to announce that it has received EU Medical Device Regulation (MDR) CE certification for its AI-powered MRI enhancement solution 'SwiftMR™'. This certification allows AIRS Medical to sell its flagship product, 'SwiftMR™,' across the EU (27 countries), Turkey, EEA (Liechtenstein, Iceland, Norway), Great Britain, and Switzerland.

The MDR CE certification is a more stringent requirement for medical devices than the previous Medical Device Directive (MDD), ensuring higher performance, quality standards, safety and clinical evaluation. MDR CE certification is essential for sales in EU and neighboring countries based on CE certification. However, many companies encounter challenges in obtaining certification and entering Europe due to enhanced assessment requirements and strict standards.

AIRS Medical, by obtaining its initial certification under MDR instead of MDD, has demonstrated adherence to stringent European standards for product performance, safety, and quality. Following FDA 510(k) expanded approval in October 2023, obtaining MDR CE certification is a notably swift pace in the AI medical device industry.

SwiftMR™ enhances MRI image quality through fine-tuned deep learning technology. It is capable of reducing MRI scan times by up to 50-percent, while enhancing image quality using AI-powered denoising and sharpening. One of the key advantages of SwiftMR™ is that it allows for improve MRI productivity without the need for additional scanner purchases or existing MRI upgrades. SwiftMR™ has expanded into over 14 countries and accumulated over 1.1M processed exams in over 300 institutions. The recent MDR CE certification is expected to further accelerate market expansion in Europe. Furthermore, AIRS Medical will showcase its latest achievements through an AI Theater Presentation at ECR(European Congress of Radiology) 2024. Visit booth #AI-04 in Austria Center Vienna from Feb 28.

Hyeseong Lee, CEO of AIRS Medical, stated, "Our MDR CE certification clearly shows AIRS Medical's capabilities in product quality and regulatory compliance." He added, "Through this certification, we will accelerate our market growth in the European market."

About AIRS Medical, Inc.

AIRS Medical is a leading healthcare AI company that envisions patient-friendly healthcare by transforming the inefficiencies in the medical industry through innovative technology, enabling more people to access healthcare when needed. AIRS Medical offers SwiftMR™, an AI-Powered MRI Reconstruction solution. It is also working on an AI-Powered Venipuncture automation solution to be released soon. Visit airsmed.com to learn more.

CONTACT: Marketing / marketing@airsmed.com / +82-70-7777-5061

Photo -

View original content:https://www.prnewswire.co.uk/news-releases/airs-medical-receives-eu-medical-device-regulation-ce-certification-for-swiftmr-302031408.html

Images

Tags

More Like This

Inspire Medical Systems, Inc. Announces CE Mark Certification of Full-Body MRI Compatibility under the European Union’s Medical Device Regulation

mediaire transforms radiology with AI, securing a European €12 million investment to fuel global growth

Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy

Augere Medical Secures MDR CE-mark for its PolypAId™ Software and System

Neoss® Group receives EU Medical Device Regulation (MDR) certifications for implants and abutments

SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking

SyMRI 15 by SyntheticMR obtains CE-Marking

SyntheticMR Receives Regulatory Approval for SyMRI 15 in Switzerland